Multiple structurally distinct compounds (Figure 1) with high affinity for sigma-2 receptors were tested for cytotoxicity against multiple pancreatic cancer cell lines in vitro (Table1) and screened for efficacy in a mouse model of pancreatic cancer with Panc02 cells (Additional file 1: figure S1). This evidence concerns the gene TMEM97 and pancreatic neoplasm.